
Dewave Life Sciences Private Limited
About Dewave Life Sciences Private Limited
Data last updated:
Dewave Life Sciences Private Limited is a private limited company based in Bhubaneswar, Odisha, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 July 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Cuttack, under CIN U24305OR2019PTC031379. Its GSTIN is 21AAHCD3547M1ZL (Odisha).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Debashish Dash (Managing Director) and Padmanav Mohapatra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No – N5/454 Ground Floor Ward No – 27 Irc Village Nayapalli, Bhubaneswar, Odisha, India – 751015.
As per the financials filed for FY 2024, the company reported a revenue of ₹16.28 Lakh, a decline of 11% compared to the previous year. For the same year it recorded a net profit of ₹81,328 (net margin 5%) and EBITDA of ₹1.08 Lakh (EBITDA margin 6.6%). Revenue has grown at a compounded annual rate (CAGR) of 21% over three years.
Court records list 1 case involving the company, including 1 filed by the company.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPlot No – N5/454 Ground Floor Ward No – 27 Irc Village Nayapalli, Bhubaneswar, Odisha, India – 751015
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Dewave Life Sciences Private Limited
The main business activity of Dewave Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Dewave Life Sciences Private Limited FY 2025 filings available
Dewave Life Sciences Private Limited reported revenue of ₹16.28 Lakh (down 11% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Dewave Life Sciences Private Limited
Revenue fell 11% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 21%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Dewave Life Sciences Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.08 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹81,328 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Dewave Life Sciences Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Dewave Life Sciences are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Dewave Life Sciences Private Limited
Dewave Life Sciences Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| B2b Health Care Private Limited | ₹16.5 Lakh (FY 2024) | •••• | •••• | -2.0% | •••• | Hyderabad, Telangana, India |
| Aabacus Formulations Private Limited | ₹16.41 Lakh (FY 2025) | •••• | •••• | •••• | Bangalore, Karnataka, India | |
| Biosome Life Science Private Limited | ₹16.41 Lakh (FY 2022) | •••• | •••• | -83.0% | •••• | Bangalore, Karnataka, India |
| Digvijay Pharma Ceuticals India Private Limited | ₹16.36 Lakh (FY 2025) | •••• | •••• | -67.0% | •••• | Thane, Maharashtra, India |
| Madhura Pharmaceuticals Private Limited | ₹16.3 Lakh (FY 2025) | •••• | •••• | 239.0% | •••• | Coimbatore, Tamil Nadu, India |
| Dewave Life Sciences Private Limited this company | ₹16.28 Lakh (FY 2024) | •••• | •••• | -11.0% | •••• | Bhubaneswar, Odisha, India |
| Arka Formulations Private Limited | ₹16.26 Lakh (FY 2024) | •••• | •••• | 252.0% | •••• | Hyderabad, Telangana, India |
| Mericks Pharmaceuticals Private Limited | ₹16.25 Lakh (FY 2025) | •••• | •••• | 26.0% | •••• | Ambala Cantt, Haryana, India |
| Tatanagar Healthcare Private Limited | ₹16.23 Lakh (FY 2025) | •••• | •••• | -22.0% | •••• | Pur Jamshedpur, Jharkhand, India |
| Ajapa Pharma Private Limited | ₹16.2 Lakh (FY 2020) | •••• | •••• | 120.0% | •••• | Hyderabad, Telangana, India |
| Aadison Pharma Private Limited | ₹16.19 Lakh (FY 2023) | •••• | •••• | 18.0% | •••• | Pune, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Dewave Life Sciences by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Dewave Life Sciences Private Limited
Dewave Life Sciences Private Limited is audited by M G G S & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| M G G S & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Dewave Life Sciences Private Limited
Dewave Life Sciences has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Debashish Dash | Managing Director | 25 Jul 2019 | 7 Years 2 Months | Current |
| Padmanav Mohapatra | Director | 25 Jul 2019 | 7 Years 2 Months | Current |
Ownership and Shareholding of Dewave Life Sciences Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Dewave Life Sciences Private Limited
Dewave Life Sciences Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Legal Cases of Dewave Life Sciences Private Limited
Dewave Life Sciences Private Limited has 1 court case on record: 1 filed by Dewave Life Sciences. All case is disposed. Status as checked on 21 Sep 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Orissa | Writ petition | Filed by the company against Chief Commissioner CT and GST | Disposed |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Dewave Life Sciences Private Limited
Employment history and EPFO contributions of people linked to Dewave Life Sciences.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Dewave Life Sciences Private Limited
Dewave Life Sciences Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Debashish Dash was appointed as Managing Director on 25 Jul 2019.
Credit Ratings, Litigation & Regulatory Alerts for Dewave Life Sciences Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Dewave Life Sciences Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Dewave Life Sciences Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Dewave Life Sciences Private Limited
Dewave Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 21AAHCD3547M1ZL | Odisha | Active | 27 Nov 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Dewave Life Sciences Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dewave Life Sciences Private Limited
Dewave Life Sciences is an active private limited company based in Bhubaneswar, Odisha, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 25 July 2019 (7+ years old) and is registered under CIN U24305OR2019PTC031379.
Dewave Life Sciences reported revenue of ₹16.28 Lakh for FY 2024 (down 11% YoY).
Dewave Life Sciences has 2 current directors:
- Debashish Dash - Managing Director
- Padmanav Mohapatra - Director
Dewave Life Sciences reported a net profit of ₹81,328 (net margin 5%) and EBITDA of ₹1.08 Lakh (EBITDA margin 6.6%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Dewave Life Sciences is 21% over three years. In the latest year (FY 2024) revenue fell 11%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Dewave Life Sciences is 21AAHCD3547M1ZL, registered in Odisha.
The CIN (Corporate Identification Number) of Dewave Life Sciences is U24305OR2019PTC031379. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dewave Life Sciences has 1 court case on record: 1 filed by the company.
Dewave Life Sciences was incorporated on 25 July 2019, making it 7+ years old. It is registered with the Registrar of Companies, Cuttack.
The peers of Dewave Life Sciences by revenue are B2b Health Care Private Limited, Aabacus Formulations Private Limited, Biosome Life Science Private Limited, Digvijay Pharma Ceuticals India Private Limited, Madhura Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations).
Debashish Dash was appointed as Managing Director on 25 Jul 2019. Padmanav Mohapatra was appointed as Director on 25 Jul 2019.